205 related articles for article (PubMed ID: 2962542)
1. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.
Andersson R; Jonsson R; Tarkowski A; Bengtsson BA; Malmvall BE
Ann Rheum Dis; 1987 Dec; 46(12):915-23. PubMed ID: 2962542
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
Andersson R; Hansson GK; Söderström T; Jonsson R; Bengtsson BA; Nordborg E
Clin Exp Immunol; 1988 Jul; 73(1):82-7. PubMed ID: 3048814
[TBL] [Abstract][Full Text] [Related]
3. Giant cell vasculitis is a T cell-dependent disease.
Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment.
Cid MC; Campo E; Ercilla G; Palacin A; Vilaseca J; Villalta J; Ingelmo M
Arthritis Rheum; 1989 Jul; 32(7):884-93. PubMed ID: 2787641
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.
Bolha L; Hočevar A; Suljič A; Jurčić V
Front Immunol; 2021; 12():791099. PubMed ID: 35003111
[TBL] [Abstract][Full Text] [Related]
6. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
Weyand CM; Schönberger J; Oppitz U; Hunder NN; Hicok KC; Goronzy JJ
J Exp Med; 1994 Mar; 179(3):951-60. PubMed ID: 8113687
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.
Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH
Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090
[TBL] [Abstract][Full Text] [Related]
8. Temporal small arterial inflammation is common in patients with giant cell arteritis.
Zhao CL; Hui Y; Amin A
Hum Pathol; 2018 Nov; 81():65-70. PubMed ID: 29953896
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis.
Wagner AD; Wittkop U; Prahst A; Schmidt WA; Gromnica-Ihle E; Vorpahl K; Hudson AP; Zeidler H
Clin Exp Rheumatol; 2003; 21(2):185-92. PubMed ID: 12747272
[TBL] [Abstract][Full Text] [Related]
10. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
[TBL] [Abstract][Full Text] [Related]
11. An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.
Schaufelberger C; Andersson R; Nordborg E; Hansson GK; Nordborg C; Wahlström J
Inflammation; 2008 Dec; 31(6):372-83. PubMed ID: 18975064
[TBL] [Abstract][Full Text] [Related]
12. Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis.
Wawryk SO; Ayberk H; Boyd AW; Rode J
J Clin Pathol; 1991 Jun; 44(6):497-501. PubMed ID: 1712368
[TBL] [Abstract][Full Text] [Related]
13. T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing alpha beta type antigen receptors and VLA-1 integrin receptors.
Schaufelberger C; Stemme S; Andersson R; Hansson GK
Clin Exp Immunol; 1993 Mar; 91(3):421-8. PubMed ID: 8383021
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies in giant cell arteritis.
Andersson R
Baillieres Clin Rheumatol; 1991 Dec; 5(3):405-12. PubMed ID: 1807818
[TBL] [Abstract][Full Text] [Related]
15. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
16. IL-6 expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis.
Manku S; Wong W; Luo Z; Seidman MA; Alabdurubalnabi Z; Rey K; Enns W; Avina-Zubieta JA; Shojania K; Choy JC
Cardiovasc Pathol; 2018; 33():55-61. PubMed ID: 29414433
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T lymphocyte subset in giant cell arteritis and related disorders.
Elling P; Olsson A; Elling H
J Rheumatol; 1990 Feb; 17(2):225-7. PubMed ID: 2138673
[TBL] [Abstract][Full Text] [Related]
18. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.
Lopez-Hoyos M; Bartolome-Pacheco MJ; Blanco R; Rodriguez-Valverde V; Martinez-Taboada VM
Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of lesions in Horton's temporal arteritis before and during corticotherapy].
Lavignac C; Jauberteau-Marchan MO; Liozon E; Vidal E; Catanzano G; Liozon F
Rev Med Interne; 1996; 17(10):814-20. PubMed ID: 8976974
[TBL] [Abstract][Full Text] [Related]
20. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
